We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Petar Kuessner Norton Rose Fulbright LLP

Results 1 to 5 of 8



Just when you thought it wasn't a derivative *

Australia - April 12 2013
In January 2012, the Corporations and Markets Advisory Committee (CAMAC) released its “Derivatives Report” (Report) following its review of the…

Co-authors: Vittorio Casamento.


Landmark case finds financial institution, reseller and ratings agency liable *

Australia - November 12 2012
IntroductionNorton Rose have acted in the matter where the Federal Court of Australia has handed down a landmark judgment on 5 November 2012 that will have significant implications for financial institutions and those involved with selling, arranging or rating complex financial products.

Co-authors: Stephen Klotz, Susanna Taylor , Vivien Fung.


Regulating OTC derivatives - Australian government releases draft legislation for public comment *

United Kingdom - July 31 2012
Following the receipt of public submissions on the Australian governments Consultation Paper, "Implementation of a framework for Australia's G20 overthecounter derivatives commitments", the government has released an exposure draft of the Corporations Legislation Amendment (Derivatives Transactions) Bill 2012 (Derivatives Bill).

Co-authors: Vittorio Casamento.


Bank capital adequacy & debt finance - greater clarity ahead *

Australia - May 8 2012
Under the accelerated implementation timeframe previously announced by the Australian Prudential Regulatory Authority, the Basel III capital reforms applicable to authorised deposit-taking institutions will progressively come into effect from 1 January 2013.

Co-authors: Tessa Hoser.


Proposed European capital requirements may influence Australia’s approach to derivatives clearing arrangements *

Australia, European Union - April 20 2012
A key driver to mandate the use of CCPs in the OTC derivatives market is to reduce counterparty risk and systemic risk that arises from bilateral trading relationships.

Co-authors: Vittorio Casamento, Tessa Hoser.


Next »